MARKET

ABBV

ABBV

AbbVie
NYSE

Real-time Quotes | Nasdaq Last Sale

88.63
+1.00
+1.14%
After Hours: 88.41 -0.22 -0.25% 19:53 11/15 EST
OPEN
88.10
PREV CLOSE
87.63
HIGH
89.19
LOW
87.26
VOLUME
8.04M
TURNOVER
--
52 WEEK HIGH
94.98
52 WEEK LOW
62.66
MARKET CAP
131.07B
P/E (TTM)
39.68
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ABBV and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ABBV News

  • Investing returns are likely to be much lower in the years ahead, so here's what to do
  • CNBC.com.1d ago
  • FDA OKs Pfizer biosimilar to Humira
  • seekingalpha.1d ago
  • Tracking Seth Klarman's Baupost Group Holdings - Q3 2019 Update
  • Seeking Alpha - Article.1d ago
  • AbbVie Option Alert: Jan 17 $92.5 Calls at the Ask: 1900 @ $1.521 vs 3034 OI; Ref=$88.955
  • Benzinga.1d ago

More

Industry

Pharmaceuticals
+1.37%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About ABBV

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).
More

Webull offers AbbVie Inc (ABBV) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.